The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options to Director

25 May 2018 07:00

RNS Number : 2598P
Norman Broadbent PLC
25 May 2018
 

Norman Broadbent plc

("Norman Broadbent" or "the Company")

Grant of Options to Director

Norman Broadbent (AIM: NBB) - a leading Professional Services firm specifically focussing on Leadership Acquisition & Advisory Services (Board & Leadership Search, Senior Interim Management, Research & Insight, Leadership Consulting & Assessment, and executive level Recruitment Solutions) announces that on 24 May 2018 the Company's Remuneration Committee recommended and approved the grant of 1,054,191 options (the "Options") to executive director Will Gerrand the Group's CFO/COO who joined the group on 5 October 2017.

The options, which are being granted under the rules of the Company's Enterprise Management Incentive Share Option Scheme 2007 (the "Scheme"), are exercisable at 13.5p per ordinary share. This represents a c.25.6% premium to the mid-market price at market close on 24 May 2018 of 10.75p.

The pricing and conditions attaching to the Options are the same as those share options issued to other executive directors as announced on 6 June 2016 in order to align the option incentive across the executive team.

The Options granted will vest in two equal tranches and are subject to different tiered vesting criteria related to: (i) share price or corporate performance; and (ii) time duration. Once vested, the options can be exercised at any time up to the seventh anniversary of the date of grant, being 24 May 2025.

50 per cent. of the options granted vest subject to certain average share prices being achieved prior to 31 July 2020 and the remaining 50 per cent. vest subject to certain audited EBITDA figures being achieved for a financial year prior to 31 December 2019. EBITDA in this context is defined as earnings before interest, tax, depreciation and amortisation, excluding any non-recurring exceptional items as determined reasonable by the Remuneration Committee. Both tranches of options vest equally over three years from the date of issue, with the first such vesting date on the first anniversary of issue being 24 May 2019 and are subject to Will Gerrand's continued employment.

The tiered average three month share prices which must be achieved for the vesting of the first tranche range between 22p and 70p per ordinary share. In addition, the audited EBITDA which must be achieved for the second tranche of options to vest ranges between approximately £600,000 and approximately £2 million. In any year where the EBITDA number achieved is less than 100 per cent. but greater than 80 per cent. of the relevant target, the number of options available for vesting would be adjusted pro rata.

The following table sets out the details of the options granted to Will Gerrand

Share Price Vesting Options

EBITDA Vesting Options

Total number of options granted

Total number of options held

Percentage of existing issued shares under option

Percentage of the fully diluted share capital*

527,095

527,096

1,054,191

1,054,191

1.96%

1.82%

* assuming that no further ordinary shares are issued by the Company between the date of this announcement and the exercise of the options.

Following the issue of the options pursuant to the Scheme as detailed above, there are options outstanding over 4,152,702 ordinary shares, equivalent to 7.16 per cent. of the fully diluted share capital of the Company as at the date of this announcement, which are exercisable at exercise prices ranging from 13.5p to 65.5p per share. At the date of this announcement the Company has 53,885,570 ordinary voting shares in issue.

 The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Will Gerrand

2

Reason for the notification

a)

Position/status

CFO / COO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norman Broadbent Plc

b)

LEI

213800E5YN5TA934XA23

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 1p each

 

GB00B3VF4Y66

b)

Nature of the transaction

Grant of share options

c)

Price(s) and volume(s)

 

 

Price:

Volume:

13.5p

1,054,191

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

24 May 2018

f)

Place of the transaction

London Stock Exchange, AIM

For further information, please contact:

Norman Broadbent plcMike Brennan / Will Gerrand

020 7484 0000

 

WH Ireland LimitedAdrian Hadden / Jessica Cave / Alex Bond

 

020 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPGUGAAUPRGQC
Date   Source Headline
5th Apr 20117:00 amRNSDirectorate Change
31st Mar 20117:00 amRNSExercise of Warrants
3rd Dec 20107:00 amRNSExpansion into Psychological Assessment Services
15th Sep 20103:48 pmPRNDirector/PDMR Shareholding
14th Sep 201010:45 amPRNResult of General Meeting
14th Sep 20107:00 amRNSInterim Results
27th Aug 20109:47 amPRNPosting of Shareholder Circular
9th Aug 201011:00 amRNSShortage of Non-Executive Directors
28th Jul 20103:40 pmPRNResult of AGM
28th Jul 20107:00 amRNSTrading Update
12th Jul 20107:00 amPRNAdviser - change of name
30th Jun 201010:21 amPRNTotal Voting Rights
29th Jun 20107:01 amRNSDirectorate Changes
29th Jun 20107:00 amRNSFinal Results for the year ended 31 December 2009
15th Jun 20108:05 amRNSNotifiable Interest
14th Jun 201010:23 amRNSResults of General Meeting
14th Jun 20107:00 amRNSJoint Venture with Russam GMS
10th Jun 20105:03 pmPRNHolding(s) in Company
27th May 20107:00 amPRNCapital Reorganisation, Subscription and Change of Name
30th Mar 201010:09 amPRNTrading Statement
16th Mar 20107:00 amPRNChange of Registered Office
29th Jan 20107:00 amPRNTotal Voting Rights
28th Jan 20101:22 pmPRNIssue of Options
22nd Jan 20109:21 amPRNIssue of Equity
7th Jan 201012:17 pmPRNDirector/PDMR Shareholding
23rd Dec 20091:48 pmPRNChange of Adviser
27th Nov 20093:48 pmPRNTrading Statement
30th Sep 20092:09 pmPRNInterim Results
31st Jul 200910:44 amPRNTotal Voting Rights
23rd Jul 20092:59 pmPRNIssue of Equity
22nd Jul 20095:39 pmPRNResult of AGM
26th Jun 20097:30 amPRNFinal Results
31st Dec 20087:00 amRNSTotal Voting Rights
4th Dec 20087:00 amRNSAcquisition and Admission
3rd Dec 20087:53 amRNSCancellation - Garner Plc - Replacement
3rd Dec 20087:00 amRNSUpdate on Acquisition
2nd Dec 20083:46 pmRNSResult of EGM
19th Nov 200811:51 amRNSSchedule 1 - Garner Plc
7th Nov 20083:37 pmPRNAcquisition
30th Sep 20087:00 amPRNHalf-yearly Report
21st May 20084:57 pmPRNResult of AGM
21st May 20084:53 pmPRNLaunch Of HR Practice
30th Apr 20082:27 pmPRNTotal Voting Rights
7th Apr 20081:42 pmPRNAdviser Change of Name
31st Mar 20088:01 amPRNChange of Adviser
31st Mar 20088:00 amPRNFinal Results
20th Dec 200710:38 amPRNDirector Dealing / Grant of Options
22nd Nov 20074:57 pmPRNDirector/PDMR Shareholding
1st Oct 200712:29 pmPRNDirector/PDMR Shareholding
20th Sep 20071:59 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.